Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  01/28/2008
 
Trade Name:  Xyzal 0.5 mg/mL Oral Solution
 
Generic Name or Proper Name (*):  levocetirizine dihydrochloride
 
Indications Studied:  Relief of symptoms associated with seasonal and perennial allergic rhinitis (SAR and PAR) and treatment of uncomplicated skin manifestations of chronic idiopathic urticaria (CIU)
 
Label Changes Summary:  Dosing information provided Studies waived in children less than 6 months of age with PAR and CIU Waived in children less than 2 years of age with SAR New dosage form pediatric
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  UCB
 
NNPS:  TRUE'
 
Therapeutic Category:  Antihistamine
 
-
-